Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune optic neuropathy: evaluation and treatment.

M J Kupersmith1, R M Burde, F A Warren

  • 1Department of Neurology, New York University Medical Center, New York.

Journal of Neurology, Neurosurgery, and Psychiatry
|November 1, 1988
PubMed
Summary

High-dose corticosteroid therapy significantly improved vision in patients with autoimmune optic neuropathy. This treatment, often combined with cytotoxic drugs, is crucial for managing this severe visual impairment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.

Journal of the neurological sciences·2016
Same author

Occlusion of the internal carotid artery based on a simple tolerance test.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences·2010
Same author

Inhibition of methotrexate-induced rheumatoid nodulosis by colchicine: evidence from an in vitro model and regression in 7 of 14 patients.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Cortical blindness, transient and otherwise, associated with detachable coil embolization of intracranial aneurysms.

AJNR. American journal of neuroradiology·2007
Same author

Visual function at baseline and 1 month in acute optic neuritis: predictors of visual outcome.

Neurology·2007
Same author

Treatment of cerebral aneurysms with hydrogel-coated platinum coils (HydroCoil): early single-center experience.

AJNR. American journal of neuroradiology·2006

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Immunology

Background:

  • Autoimmune optic neuropathy can cause severe vision loss.
  • Conventional corticosteroid doses are often insufficient for treatment.
  • Collagen vascular disease is frequently associated with this condition.

Purpose of the Study:

  • To evaluate the efficacy of megadose corticosteroid therapy for autoimmune optic neuropathy.
  • To determine the necessity of combination therapy for sustained vision improvement.
  • To emphasize the importance of differentiating autoimmune optic neuropathy from other optic neuritis causes.

Main Methods:

  • Retrospective analysis of 14 patients with progressive or recurrent optic neuropathy.
  • Administration of megadose corticosteroid therapy.

Related Experiment Videos

  • Follow-up assessment of visual acuity and treatment outcomes.

    • Main Results:

    • 11 out of 12 patients experienced vision improvement with megadose corticosteroids.
    • Nine patients required continued oral prednisone and cytotoxic drugs for vision maintenance.
    • Severe visual loss (acuity < 20/200) was common at presentation.

    Conclusions:

    • Megadose corticosteroid therapy is effective in improving vision in autoimmune optic neuropathy.
    • Combination therapy with cytotoxic agents is often necessary for long-term vision preservation.
    • Accurate diagnosis is essential to distinguish autoimmune optic neuropathy from idiopathic optic neuritis or multiple sclerosis for appropriate management.